[ET Net News Agency, 4 November 2024] MEDBOT-B (02252) rose 10.4% to HK$9.46, breaking
above the 10-D SMA of HK$9.125.
It hits an intra-day high of HK$9.49, and an intra-day low of HK$8.5. The total shares
traded was 6.46 million, with a value of HK$58.63m. The active buy/sell ratio is 58:42,
with net buying turnover of HK$9.33m. BNP PARIBAS SEC (ASIA) accounts for greatest net
responsive buying turnover of HK$1.72m, with volume weighted average price of HK$9.146.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$1.47m,
with volume weighted average price of HK$9.112.

Basic Information
=================

---------------------------------
Nominal 9.460 % Chg +10.38%
High 9.490 Low 8.500
Shares Tr 6.46m Turnover 58.63m
10-D SMA 9.125 %H.V 134.366
20-D SMA 9.590 VWAP 9.078
50-D SMA 8.489 RSI14 52.212
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 58:42, with net buying
turnover of HK$9.33m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
MEDBOT-B (02252) 9.46 +10.38
MICROPORT (00853) 6.58 +1.54
WEIGAO GROUP (01066) 4.94 +1.65
LIFETECH SCI (01302) 1.67 -1.18
AK MEDICAL (01789) 4.66 -1.27
MICROPORT NEURO (02172) 9.32 +0.11
GAUSH MEDITECH (02407) 10.40 -1.14
ANGELALIGN (06699) 63.70 +2.58
HAOHAI BIOTEC (06826) 30.45 Unchanged
KANGJI MEDICAL (09997) 5.91 +0.17
-----------------------------------------------
(ed)